Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regenicin Inc (CE) | RGIN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0001 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0001 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.000001 - 0.0054 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0001 | USD |
Regenicin Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 15.38k | 153.77M | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regenicin (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGIN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 15,000 | 0.00 | 0.00% |
| 1 Month | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 70,384 | 0.00 | 0.00% |
| 3 Months | 0.0001 | 0.005 | 0.0001 | 0.0001551 | 204,651 | 0.00 | 0.00% |
| 6 Months | 0.0001 | 0.005 | 0.000001 | 0.0001078 | 234,347 | 0.00 | 0.00% |
| 1 Year | 0.0016 | 0.0054 | 0.000001 | 0.0004008 | 119,787 | -0.0015 | -93.75% |
| 3 Years | 0.03445 | 0.03445 | 0.000001 | 0.0100825 | 67,423 | -0.03435 | -99.71% |
| 5 Years | 0.02 | 0.04125 | 0.000001 | 0.0132499 | 59,087 | -0.0199 | -99.50% |
Regenicin (CE) Description
| Regenicin, Inc. is a development stage company focusing on next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin. It is devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets with PermaDerm - the only tissue-engineered skin prepared from a patient's own skin cells. Company is headquartered in Little Falls, NJ. |
